Novel Therapies for Inherited Retinal Dystrophies
Christine Nichols Kay · 2024
Read Novel Therapies for Inherited Retinal Dystrophies by Christine Nichols Kay (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642238.txt.
Description
Christine Nichols Kay surveys in this 2024 review a decade of new therapies for inherited retinal dystrophies, the gene-driven diseases that steal sight. The 2017 approval of the first retinal gene therapy opened the gate. Since then, programs for several diseases have reached late-stage trials, and early cohorts show closed splits in the retina and better light sensitivity.
Kay stresses a stubborn catch: trials can miss their preset endpoints even when a therapy works, because rare diseases recruit slowly and vision is hard to score. Regulators seem sympathetic to flexible paths for orphan drugs. The review maps the pipeline and the endpoint problem together. Families wait on each of these trials.
Catalog record
| CREATOR | Christine Nichols Kay |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |